Skip to Content

Join the 'Leukemia' group to help and get support from people like you.

Leukemia News

Related terms: Cancer, Leukemia

Black Americans' Cancer Rates Differ by Birthplace

Posted 11 days ago by Drugs.com

THURSDAY, April 13, 2017 – Cancer rates differ between African- and U.S.-born black Americans, a new study finds. "Typically, cancer occurrence among blacks in the United States is presented as one homogenous group, with no breakdown by country or region of birth," said study co-author Dr. Ahmedin Jemal, an American Cancer Society epidemiologist. "Our study shows that approach masks important potential differences that may be key to guiding cancer prevention programs for African-born black immigrants," Jemal added. The researchers analyzed 2000-2012 U.S. data to compare rates of the top 15 cancers in African-born blacks to U.S.-born blacks. Blacks born in sub-Sahara Africa had much higher rates of infection-related cancers (liver, stomach and Kaposi sarcoma) than U.S.-born blacks. They also had higher rates of blood cancers (leukemia and non-Hodgkin lymphoma), prostate cancer and ... Read more

Related support groups: Cancer, Prostate Cancer, Leukemia, Thyroid Cancer, Kaposi's Sarcoma

Gleevec Keeps a Leukemia in Check for More Than a Decade: Study

Posted 9 Mar 2017 by Drugs.com

WEDNESDAY, March 8, 2017 – The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment – with no signs of additional safety risks, a new study finds. Gleevec – known generically as imatinib – was hailed as a "wonder drug" when it was introduced in 2001 for treating chronic myeloid leukemia (CML). CML is a type of blood cancer that strikes about 5,000 Americans each year, according to the U.S. National Cancer Institute (NCI). Before Gleevec, a CML diagnosis "amounted to a death sentence," the institute said. Now, most cases can be controlled, with either Gleevec or related drugs that have been developed since then. The new findings offer more evidence that the early "hype" around Gleevec was correct, said lead researcher Dr. Andreas Hochhaus, of Jena University Hospital in Germany. Of more than 500 CML patients given Gleevec as their initial ... Read more

Related support groups: Leukemia, Chronic Myelogenous Leukemia (CML), Lung Cancer, Gleevec, Non-Small Cell Lung Cancer, Melanoma, Chronic Lymphocytic Leukemia (CLL), Tasigna, Sprycel, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Dasatinib, Nilotinib, Imatinib, Acute Lymphocytic Leukemia, Acute Myeloblastic Leukemia

Childhood Cancer Survivors Living Longer

Posted 28 Feb 2017 by Drugs.com

TUESDAY, Feb. 28, 2017 – Children who survive cancer are living longer. And one reason may be that fewer childhood cancers are treated with radiation today than were 20 years ago, researchers suggest. Although the study can't prove a cause-and-effect link, the researchers found that as use of radiation in childhood cancers declined dramatically, so did the number of kids with cancers that returned. "The most ominous late effect of pediatric cancer treatment is a second [cancer]. This study shows efforts to reduce the late effects of treatment are paying off," said study leader Dr. Gregory Armstrong. He's with St. Jude Children's Research Hospital's Department of Epidemiology and Cancer Control in Memphis, Tenn. "The risk of second cancers for survivors increases with age, so it is good to see the reduction emerging early in survivorship while survivors are still young," Armstrong said ... Read more

Related support groups: Cancer, Leukemia, History - Radiation Therapy, Neutropenia Associated with Radiation

Most Adult Survivors of Childhood Cancers Enjoy Good Sexual Health

Posted 6 Feb 2017 by Drugs.com

MONDAY, Feb. 6, 2017 – Treatment received in childhood to help fight cancer can have an impact on sexual health in adulthood, a new report suggests. However, the study also found that most adult survivors of childhood cancer report having satisfying sexual and romantic lives. "As positive as it is to see this, we still should be closely monitoring sexual health in adults who did have cancer treatment as children, especially those needing high-dose neurotoxic [brain-harming] treatments," said Dr. Matthew Lorber, who reviewed the new findings. He directs child and adolescent psychiatry at Lenox Hill Hospital in New York City. The new research was published online Feb. 6 in the journal Cancer and was led by Vicky Lehmann, of Nationwide Children's Hospital and Ohio State University in Columbus. Lehmann's team noted that treatment for childhood cancer can harm the developing brain in a way ... Read more

Related support groups: Birth Control, Contraception, Cancer, Erectile Dysfunction, Methotrexate, Sexually Transmitted Diseases, Female Infertility, Leukemia, Fluorouracil, Xeloda, Hydroxyurea, Ovulation Induction, Mercaptopurine, Hydrea, Dacogen, Capecitabine, Gemzar, Sexual Deviations or Disorders, Gemcitabine, Hypoactive Sexual Desire Disorder

Gene Therapy Helps 2 Babies Fight Type of Leukemia

Posted 25 Jan 2017 by Drugs.com

WEDNESDAY, Jan. 25, 2017 – Two infants with an advanced form of leukemia are in remission after treatment with genetically tweaked immune system cells, British researchers report. Both babies had run out of treatment options for their cancer, known as B-cell acute lymphoblastic leukemia, or ALL. But, after treatment with genetically altered T-cells – a type of immune system cell – both went into remission. The babies are now "at home and doing well," said Dr. Waseem Qasim, one of the doctors reporting on the cases. They will still have to be monitored for "some time," said Qasim, a professor of cell and gene therapy at University College London. Small trials are under way, he said, to see if the therapy can be more widely applied. ALL is a cancer of the white blood cells that strikes roughly 6,000 U.S. adults and children each year, according to the American Cancer Society. The ... Read more

Related support groups: Leukemia, Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia

Therapeutic Vaccine Shows 'Game-Changing' Promise Against a Leukemia

Posted 7 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 7, 2016 – An anti-cancer vaccine made from a leukemia patient's own cells can dramatically increase the chance of long-term survival against the deadly disease, a new study indicates. Patients with acute myeloid leukemia – one of the most aggressive blood cancers – must undergo intense chemotherapy to beat back the disease. And then they almost always relapse within a couple of years, explained senior researcher Dr. David Avigan. He is chief of hematological malignancies and director of the Cancer Vaccine Program at the Beth Israel Deaconess Medical Center in Boston. But a handful of leukemia patients have been in remission for nearly five years now, thanks to a new vaccine created from a fusion of leukemia cells and immune cells drawn from their own bodies. The vaccine has produced long-term remission for 70 percent of a small group of 17 vaccinated patients with an ... Read more

Related support groups: Leukemia, Acute Myeloid Leukemia, Diagnosis and Investigation, Acute Promyelocytic Leukemia, Bone Marrow Depression/Low Blood Counts

Earnings Fall After a Child's Cancer Diagnosis

Posted 21 Nov 2016 by Drugs.com

MONDAY, Nov. 21, 2016 – After a child's cancer diagnosis, parents' income often drops and mothers frequently stop working, a new study finds. Moreover, the financial effects of a cancer diagnosis can last years, with mothers' earnings dipping significantly more than fathers' pay, the study suggests. Mothers' incomes fell 21 percent in the first year after a child developed cancer versus 10 percent for fathers, according to the study. "In addition to differences between mothers and fathers, we found that a younger age of parents [and] lower level of education ... were associated with more adverse effects on income," said study author Emma Hoven, of the Karolinska Institute in Sweden. Researchers tracked more than 3,600 parents in Sweden whose 1,900 children were diagnosed with cancer between 2004 and 2009. The parents were compared to a group of about 35,000 parents whose children did ... Read more

Related support groups: Cancer, Leukemia

Experimental Immune Cell Rx Shows Promise for Leukemia

Posted 21 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 21, 2016 – An experimental therapy that revs up the immune system's cancer-fighting ability may help treat some leukemia patients who face a grim prognosis, a small study suggests. The treatment involves infusions of "natural killer" (NK) cells taken from a healthy donor and chemically "trained" to go after tumor cells. Researchers found that of nine patients with acute myeloid leukemia (AML) who received the therapy, four went into complete remission for as long as six months. The findings are preliminary, and the therapy remains experimental, the researchers pointed out. But experts said the results are encouraging considering the outlook these AML patients faced before the trial. Their cancer had either failed to respond to standard chemotherapy or had come back, and they had run out of options. "When you see this kind of response in these patients, it's ... Read more

Related support groups: Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Diagnosis and Investigation

Childhood Cancer Death Rates Continue to Fall: CDC

Posted 16 Sep 2016 by Drugs.com

FRIDAY, Sept. 16, 2016 – The number of U.S. children who die from cancer has fallen 20 percent since 1999, and leukemia is no longer the top killer, a new federal government report shows. The decline continues a trend that began back in the 1970s, experts said. What's new is that leukemia – the most common type of childhood cancer – is no longer the leading cause of cancer deaths. Survival among children with leukemia has improved to the degree that brain cancer now tops the list. "It had been leukemia for decades, but only recently has there been this switch," said lead researcher Sally Curtin, who is with the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS). It's not that deaths from childhood brain cancer are rising, according to Curtin. Instead, the rate has remained stubbornly stable, while leukemia deaths keep declining, she ... Read more

Related support groups: Cancer, Hairy Cell Leukemia, Leukemia, Brain Tumor

For Teens With Leukemia, Pregnancy Tests Often Neglected

Posted 12 Sep 2016 by Drugs.com

MONDAY, Sept. 12, 2016 – Many teen girls with leukemia aren't checked for pregnancy before they receive chemotherapy drugs that can cause birth defects, a new study finds. Despite the risk of birth defects posed by these drugs, there are no standardized guidelines for pregnancy screening in teen cancer patients, the researchers said. "Since nearly all chemotherapy agents used for childhood/adolescent acute leukemia can cause potential harm to a developing fetus, our findings indicate a need for standardized pregnancy screening practices for adolescent patients being treated for cancer," said study author Dr. Pooja Rao. She was with a team from the University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia when the study was conducted. The researchers analyzed data from 10- to 18-year-old girls in the United States diagnosed with acute lymphoblastic leukemia ... Read more

Related support groups: Birth Control, Contraception, Emergency Contraception, Postcoital Contraception, Leukemia, Vitamin/Mineral Supplementation during Pregnancy/Lactation

Strides Made in Treating Childhood Cancer: Report

Posted 11 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – Significant progress has been made in treating childhood cancers, but more needs to be done to fight tougher cancers and protect the long-term health of survivors, a new report says. In 2016, more than 14,600 children aged 19 and younger will be diagnosed with some form of pediatric cancer, and 1,850 will die, according to the American Cancer Society (ACS), which compiled the report with the Alliance for Childhood Cancer. "The numbers here tell a compelling story," said Katherine Sharpe, senior vice president of patient and caregiver support at the ACS. "We have seen significant progress when it comes to developing effective treatments for a variety of pediatric cancer sites and ultimately saving lives," she said in an ACS news release. "But when we expand our view to look at all pediatric cancers, as well as long-term health and survival, it becomes clear that ... Read more

Related support groups: Cancer, Leukemia, Brain Tumor, Neuroblastoma

Cord-Blood Transplants Show Promise in Leukemia Treatment

Posted 8 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Bone marrow or stem cell transplants can save the lives of adults and children with leukemia, but an ideal donor often isn't available. In those cases, umbilical cord blood may work as well as current alternatives – or even better in some cases, a new study suggests. "Often, cord-blood transplant is thought to be only as the last resource for patients without donors. But cord blood does not have to be considered only an alternative donor source," said study lead author Dr. Filippo Milano. "In centers with experience, it can yield to great outcomes," said Milano, an assistant member of the Clinical Research Division at Fred Hutchinson Cancer Research Center in Seattle. At issue: How best to treat the blood cancer leukemia and a related condition called myelodysplastic syndrome? One approach replaces a patient's blood-producing bone marrow through a ... Read more

Related support groups: Leukemia, Myelodysplastic Syndrome, Diagnosis and Investigation

Cancer Drug Shows Early Promise for Parkinson's Disease

Posted 13 Jul 2016 by Drugs.com

TUESDAY, July 12, 2016 – A drug used to treat leukemia has shown initial signs of promise for advanced cases of Parkinson's disease, researchers are reporting. Experts stressed that the study was small, and primarily designed to see whether the drug – called nilotinib (brand name Tasigna) – is even safe for Parkinson's patients. It did appear "relatively safe" among the dozen patients studied, said Dr. Charbel Moussa, the senior researcher on the work. One patient had to withdraw from the study because of heart complications. But the drug was "well tolerated" in the remaining patients, according to Moussa, an assistant professor of neurology at Georgetown University Medical Center, in Washington, D.C. Plus, he said, there were hints of benefit. The researchers found signs that the drug boosted the brain's production of dopamine, a chemical that helps regulate movement. It also ... Read more

Related support groups: Parkinson's Disease, Leukemia, Tasigna, Nilotinib, Parkinsonian Tremor, Parkinsonism, Parkinson's Disease Psychosis

Exercise May Cut Risk of 13 Cancers, Study Suggests

Posted 16 May 2016 by Drugs.com

MONDAY, May 16, 2016 – Exercise may significantly reduce your risk for many types of cancer, including some of the most lethal forms of the disease, a large review suggests. Working out for even a couple of hours a week appears to shrink the risk of breast, colon and lung cancer, said researchers who looked at 1.4 million adults. "Those are three of the four major cancers that affect Americans today," said Marilie Gammon. She is a professor of epidemiology with the University of North Carolina at Chapel Hill Gillings School of Public Health. And fitness buffs, take heart – your cancer risk appears to continue to decline as you rack up hours of physical activity, with no apparent upper plateau, said study lead author Steven Moore, an investigator with the U.S. National Cancer Institute. "The more activity, the more the benefit," Moore said. "As people did more, their risk continued to ... Read more

Related support groups: Cancer, Breast Cancer, Leukemia, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma, Endometrial Cancer, Small Cell Lung Cancer, Acute Myeloid Leukemia, Bladder Cancer, Stomach Cancer, Head and Neck Cancer, Breast Cancer, Prevention, Acute Lymphoblastic Leukemia, Gastric Cancer, Osteolytic Bone Lesions of Multiple Myeloma, Urinary Tract Cancer, Acute Myeloblastic Leukemia

Radon in the Home May Be Linked to Blood Cancers in Women

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – New research suggests a strong link between exposure to high levels of radon in the home and women's risk of blood cancers. Radon is a naturally occurring radioactive gas, the U.S. Environmental Protection Agency says. It's known to cause lung cancer and is the second leading cause of lung cancer in the United States, the researchers said. The American Cancer Society collected information over 19 years on more than 140,000 Americans as part of a prevention study. During that time, just over 3,000 cases of blood cancer were diagnosed. The cancers included leukemia, lymphoma and myeloma, the study found. Women who lived in counties with the highest radon levels were 63 percent more likely to develop blood cancers than those in counties with the lowest radon levels. There was no link seen among men, the study noted. The study was published online recently in the ... Read more

Related support groups: Cancer, Leukemia, Lung Cancer, Non-Small Cell Lung Cancer, Lymphoma, Multiple Myeloma, Poisoning, Small Cell Lung Cancer, Toxic Reactions Incl Drug and Substance Abuse

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Chronic Myelogenous Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia, Hairy Cell Leukemia, Acute Myeloblastic Leukemia, Chronic Eosinophilic Leukemia, Meningeal Leukemia, Blood Disorders

Related Drug Support Groups

prednisone, dexamethasone, triamcinolone, Decadron, Sprycel, Kenalog-40, dasatinib, Deltasone, cytarabine, view more... Liquid Pred, Sterapred DS, Dexone, Adrenocot LA, Adrenocot, Cytosar, Cytosar-U, Fludara, Sterapred, fludarabine, Dexpak Taperpak, Prednicot, Prednicen-M, Orasone, Clinacort, Dalalone LA, Decaject, Decaject LA, Zema Pak, Dalalone DP, Dalalone, Dexamethasone Intensol, Oforta, Baycadron, Idamycin, Dexasone LA, Decadron-LA, Solurex LA, Dexacen-4, Hexadrol, Tarabine PFS, idarubicin, Idamycin PFS, Solurex, De-Sone LA, Dexacorten, Medidex, Medidex LA, Primethasone, Dexone LA, Dexacort-LA, Dexasone, Meticorten